Immunogen (IMGN) Director Buys 20K Shares
Tweet
Share
E-mailGet Alerts IMGN Hot Sheet
Down)Join SI Premium – FREE
Immunogen (NASDAQ: IMGN) Director, Mark Alan Goldberg, bought 20,000 shares on 12/15 at $1.80
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Visa (V) stock rises as Q2 earnings, revenue come ahead of estimates
- PENN Entertainment (PENN) Climbs after Hedge Fund Greenlight Takes Stake
- Tesla (TSLA) erases gains, drops to $140 again
Create E-mail Alert Related Categories
Insiders' BlogSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
